2023-01-01から1ヶ月間の記事一覧
" Peimine ameliorates pulmonary fibrosis via the inhibition of M2-type macrophage polarization through the suppression of P38/Akt/STAT6 signals Z Cai, Y Tian, J Li, P Zhao, J Li, X Mei… - Bioscience …, 2022 - portlandpress.com … of M2 macr…
" Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3 Q Li, Y Cheng, Z Zhang, Z Bi, X Ma… - Clinical and …, 2022 - Wiley Online Library … from various M2 macrophages …
<><><> [HTML] What Do We Need to Know About Rising Rates of Idiopathic Pulmonary Fibrosis? A Narrative Review and Update JV Pergolizzi, JA LeQuang, M Varrassi, F Breve… - Advances in Therapy, 2023 … The most common type of idiopathic inter…
" Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease M Ohgushi, N Ogo, T Yanagihara, Y Harada… - Internal …, 2022 - jstage.jst.go.jp … tacrolimus in the post-acute phase, but pulmonary fibrosis progressed in the late phase. T…
" [HTML] Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signaling B Liu, Q Jiang, R Chen, S Gao, Q Xia, J Zhu, F Zhang… - International …, 2022 … Idiopathic pulmonary fib…
" [HTML] Deciphering the Antifibrotic Property of Metformin A Septembre-Malaterre, C Boina, A Douanier… - Cells, 2022 - mdpi.com … metformin … metformin can reverse the bleomycin-induced mouse lung fibrosis pattern [41,43]. However, it is …
" Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis X Wu, X Xiao, X Chen, M Yang, Z Hu… - Frontiers in …, 2022 - ncbi.nlm.nih.gov … Background: Pulmonary fibr…
令和4年11月5日 神奈川県立循環器呼吸器病センター 第32回 公開医療講座 ～コロナ禍の間質性肺炎 part 2～ のYoutube配信動画がとてもわかりやすかったので、ご紹介します。 youtu.be #2 「間質性肺炎の日常生活の過ごし方」 慢性呼吸器疾患看護認定看護師 …
西横浜国際総合病院 内科 本間 栄 医師による間質性肺炎の基礎知識についてのYoutube動画がとてもわかりやすかったので、ご紹介します。 間質性肺炎 第一部 基礎編 youtu.be 間質性肺炎 第二部 原因不明の間質性肺炎 youtu.be 間質性肺炎 第三部 原因の明ら…
<><><> [PDF] Multi-Step Extracellular Matrix Remodelling and Stiffening in the Development of Idiopathic Pulmonary Fibrosis C Júnior, A Ulldemolins, M Narciso, I Almendros… - International Journal of …, 2023 … Idiopathic pulmonary fibrosis…
" Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway X Pei, F Zheng, Y Li, Z Lin, X Han, Y Feng, Z Tian… - Cells, 2022 - mdpi.com … mechanism of NEN in IPF. Based on the data presen…
" Discovery of 4-methylquinazoline based PI3K inhibitors for the potential treatment of idiopathic pulmonary fibrosis S Lin, J Jin, Y Liu, H Tian, Y Zhang, R Fu… - Journal of Medicinal …, 2019 - ACS Publications … In a bleomycin-induced mo…
" A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis PT Lukey, SA Harrison, S Yang, Y Man… - European …, 2019 - Eur Respiratory Soc … in IPF lung. This study contributes not only to understand…
" PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung Injury JP Margaria, L Moretta, JC Alves-Filho, E Hirsch - Biomedicines, 2022 - mdpi.com … PI3K/Akt pathway that are currently under clinica…
" [HTML] Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis J Wang, K Hu, X Cai, B Yang, Q He, J Wang… - … Pharmaceutica Sinica B, 2021 - Elsevier … IPF, and demonstrates that PI3K/AKT can directly participate to t…
" [HTML] The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF) F Xu, N Tanabe, DM Vasilescu, JE McDonough… - EBioMedicine, 2021 - Elsevier … 3–5 years of diagnosis of idiopathic …
<><><> [HTML] Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases V Pulito-Cueto, F Genre, R López-Mejías… - International Journal of …, 2023 … , as well as its use…
" Hsp90 inhibition and modulation of the proteome: Therapeutical implications for idiopathic pulmonary fibrosis (ipf) RML Colunga Biancatelli, P Solopov… - International Journal of …, 2020 - mdpi.com … Idiopathic Pulmonary fibrosis (IPF) i…
" … of transcriptomics data for the prediction and prioritization of membrane-associated biomarkers for idiopathic pulmonary fibrosis (IPF) by bioinformatics approach S Mishra, MI Shah, SU Kumar, DT Kumar… - Advances in protein …, 2021 - E…
" [HTML] TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling G Epstein Shochet, E Brook… - Respiratory …, 2020 - respiratory-research.biomedcentral … … Idio…
" Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients TA Taz, K Ahmed, BK Paul, M Kawsar… - Briefings in …, 2021 - academic.oup.com … , idiopathic pulmonary fibrosis (IPF) is…
" Regeneration or repair? The role of alveolar epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis (IPF) P Confalonieri, MC Volpe, J Jacob, S Maiocchi… - Cells, 2022 - mdpi.com … Idiopathic pulmonary fibrosis (IPF) accoun…
" Idiopathic pulmonary fibrosis: disease mechanisms and drug development P Spagnolo, JA Kropski, MG Jones, JS Lee… - Pharmacology & …, 2021 - Elsevier … Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease of unknown cause …
癒しの音楽をお届けいたします。 演奏は私のハープの師匠の邊見先生です。 youtu.be <><><> Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: A Review Y Tian, C Duan, J Feng, J Liao, Y Yang, W Sun - The Int…
" Antifibrotic drug use in patients with idiopathic pulmonary fibrosis. Data from the IPF-PRO Registry ML Salisbury, CS Conoscenti, DA Culver… - Annals of the …, 2020 - atsjournals.org Rationale: Two antifibrotic medications, nintedanib an…
" The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis T Tran, M Šterclová, N Mogulkoc, K Lewandowska… - Respiratory …, 2020 - Springer … Several registries of idiopathic…
" Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis G Sheng, P Chen, Y Wei, H Yue, J Chu, J Zhao… - Chest, 2020 - Elsevier … group of disorders with pulmonary parenchyma involvement; idiopathic pulmonary …
" The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis A Guenther, E Krauss, S Tello, J Wagner, B Paul… - Respiratory …, 2018 - Springer … This paper describes baseline…
" Global incidence and prevalence of idiopathic pulmonary fibrosis TM Maher, E Bendstrup, L Dron… - Respiratory …, 2021 - respiratory-research.biomedcentral … … Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating lung disease…
" Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF) S Saito, A Alkhatib, JK Kolls, Y Kondoh… - Journal of thoracic …, 2019 - ncbi.nlm.nih.gov … for the treatment of idiopathic pulmonary fibrosis (IPF). Based …
